Amanote Research
Register
Sign In
Premixed Insulin Treatment for Type 2 Diabetes Mellitus in China: Patient and Physician Perceptions
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.03.1260
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2016
Authors
K. Wang
Y. Chen
V. Higgins
L. Qian
Publisher
Elsevier BV
Related search
Patient-Reported Frequency and Impact of Hypoglycemia in Type-2 Diabetes Patients Receiving Premixed Insulin in Seven European Countries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed With Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Serum Insulin and Insulin Resistance in the Off-Springs of Type 2 Diabetes Mellitus
Journal of Diabetes & Metabolism
PDB40 Economic Burden of Type 2 Diabetes Mellitus in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Vildagliptin: Optimal Control in Type 2 Diabetes Mellitus Treatment
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Momordica Charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus
Journal of Medicinal Food
Medicine
Nutrition
Dietetics
Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Clinical Study of Treatment Switching From Premixed Insulin to Basal Insulin Combined With Oral Hypoglycemic Drugs in Patients With Type 2 Diabetes
Diabetology and Metabolic Syndrome
Internal Medicine
Endocrinology
Metabolism
Diabetes
Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan
Journal of Health Economics and Outcomes Research
